LUPUS NEPHRITIS
Clinical trials for LUPUS NEPHRITIS explained in plain language.
Never miss a new study
Get alerted when new LUPUS NEPHRITIS trials appear
Sign up with your email to follow new studies for LUPUS NEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New lupus drug shows promise in early trial
Disease control CompletedThis early-stage study tested a new drug called KZR-616 for people with lupus, including those with kidney inflammation (lupus nephritis). The drug was given as a weekly injection under the skin for 13 or 24 weeks, in addition to patients' standard lupus medications. The main goa…
Matched conditions: LUPUS NEPHRITIS
Phase: PHASE1, PHASE2 • Sponsor: Kezar Life Sciences, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New lupus drug safety under scrutiny in taiwan
Disease control CompletedThis study observed 72 patients in Taiwan with lupus nephritis (kidney inflammation from lupus) who were newly prescribed Myfortic. The main goal was to monitor the drug's safety and side effects over 12 months of routine use. Researchers also tracked whether patients' kidney fun…
Matched conditions: LUPUS NEPHRITIS
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Kidney-Saving drug showdown for lupus patients
Disease control CompletedThis study tested two different drug combinations to control lupus nephritis, a serious kidney complication of lupus. Researchers compared tacrolimus plus steroids against mycophenolate mofetil plus steroids in 130 Asian patients. The goal was to see which combination better prot…
Matched conditions: LUPUS NEPHRITIS
Phase: PHASE3 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
New shot aims to protect kidneys in lupus patients
Disease control CompletedThis study tested whether adding a new injectable drug called BI 655064 to standard treatment could better control kidney damage in people with active lupus nephritis. 121 adults with this serious kidney complication received either one of three drug doses or a placebo injection …
Matched conditions: LUPUS NEPHRITIS
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Head-to-Head: which lupus drug protects kidneys better?
Disease control CompletedThis study looked back at medical records to compare two existing drugs, telitacicept and belimumab, for treating lupus nephritis, a serious kidney complication of lupus. It involved 56 adults who had already taken one of the drugs for at least 12 weeks. The goal was to see which…
Matched conditions: LUPUS NEPHRITIS
Sponsor: Yipeng Liu • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New drug tested to halt kidney damage in lupus patients
Disease control CompletedThis study tested whether adding an intravenous drug called efgartigimod to standard treatment could better control lupus nephritis, a serious kidney complication of lupus. It involved 73 Chinese adults with active kidney inflammation from lupus. The main goal was to see if the d…
Matched conditions: LUPUS NEPHRITIS
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Scientists hunt for lupus kidney damage clue in blood
Knowledge-focused CompletedThis study aimed to find a better way to spot kidney damage in people with lupus. Researchers tested blood samples from 100 lupus patients to see if a specific antibody (anti-GBM) was more common in those with kidney problems. The goal was to see if this antibody could serve as a…
Matched conditions: LUPUS NEPHRITIS
Phase: NA • Sponsor: CHU de Reims • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:07 UTC